EdgarLookup

ROYAL GOLD INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that ROYAL GOLD INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
45.2%
Profit Margin
Net income ÷ revenue
4.9%
Return on Assets
Net income ÷ assets
0.33x
Debt-to-Equity
Total liabilities ÷ equity
+43.2%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.03B Feb 19, 2026
FY2025 Dec 31, 2024 $719.40M Feb 19, 2026
FY2025 Dec 31, 2023 $605.72M Feb 19, 2026
FY2024 Dec 31, 2022 $603.21M Feb 13, 2025
FY2023 Dec 31, 2021 $342.95M Feb 15, 2024
FY2023 Jun 30, 2021 $615.86M Feb 15, 2024
FY2020 Jun 30, 2020 $119.97M Aug 6, 2020
FY2020 Mar 31, 2020 $136.44M Aug 6, 2020
FY2020 Dec 31, 2019 $123.64M Aug 6, 2020
FY2020 Sep 30, 2019 $118.77M Aug 6, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2016 Jun 30, 2016 $288.81M Aug 11, 2016
FY2016 Jun 30, 2015 $244.57M Aug 11, 2016
FY2016 Jun 30, 2014 $228.00M Aug 11, 2016

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $714.33M Feb 19, 2026
FY2025 Dec 31, 2024 $471.17M Feb 19, 2026
FY2025 Dec 31, 2023 $343.39M Feb 19, 2026
FY2024 Dec 31, 2022 $323.10M Feb 13, 2025
FY2023 Dec 31, 2021 $186.74M Feb 15, 2024
FY2023 Jun 30, 2021 $333.00M Feb 15, 2024
FY2022 Jun 30, 2020 $236.06M Feb 16, 2023
FY2021 Jun 30, 2019 $178.55M Aug 12, 2021
FY2020 Jun 30, 2018 $209.35M Aug 6, 2020
FY2019 Jun 30, 2017 $192.24M Aug 8, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $466.28M Feb 19, 2026
FY2025 Dec 31, 2024 $332.02M Feb 19, 2026
FY2025 Dec 31, 2023 $239.44M Feb 19, 2026
FY2024 Dec 31, 2022 $238.98M Feb 13, 2025
FY2023 Dec 31, 2021 $138.34M Feb 15, 2024
FY2023 Jun 30, 2021 $302.53M Feb 15, 2024
FY2020 Jun 30, 2020 $49.02M Aug 6, 2020
FY2020 Mar 31, 2020 $38.55M Aug 6, 2020
FY2020 Dec 31, 2019 $41.32M Aug 6, 2020
FY2020 Sep 30, 2019 $70.45M Aug 6, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $638.17M Feb 19, 2026
FY2025 Dec 31, 2024 $429.90M Feb 19, 2026
FY2025 Dec 31, 2023 $303.20M Feb 19, 2026
FY2024 Dec 31, 2022 $283.71M Feb 13, 2025
FY2023 Dec 31, 2021 $171.36M Feb 15, 2024
FY2023 Jun 30, 2021 $337.60M Feb 15, 2024
FY2020 Jun 30, 2020 $44.58M Aug 6, 2020
FY2020 Mar 31, 2020 $52.28M Aug 6, 2020
FY2020 Dec 31, 2019 $53.31M Aug 6, 2020
FY2020 Sep 30, 2019 $48.78M Aug 6, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $704.85M Feb 19, 2026
FY2025 Dec 31, 2024 $529.50M Feb 19, 2026
FY2025 Dec 31, 2023 $415.79M Feb 19, 2026
FY2024 Dec 31, 2022 $417.35M Feb 13, 2025
FY2023 Dec 31, 2021 $248.78M Feb 15, 2024
FY2023 Jun 30, 2021 $407.15M Feb 15, 2024
FY2022 Jun 30, 2020 $340.75M Feb 16, 2023
FY2021 Jun 30, 2019 $253.17M Aug 12, 2021
FY2020 Jun 30, 2018 $328.82M Aug 6, 2020
FY2019 Jun 30, 2017 $266.85M Aug 8, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.54B Feb 19, 2026
FY2025 Dec 31, 2024 $3.39B Feb 19, 2026
FY2024 Dec 31, 2023 $3.36B Feb 13, 2025
FY2023 Dec 31, 2022 $3.53B Feb 15, 2024
FY2022 Dec 31, 2021 $2.76B Feb 16, 2023
FY2021 Jun 30, 2021 $2.65B Aug 12, 2021
FY2021 Jun 30, 2020 $2.77B Aug 12, 2021
FY2020 Jun 30, 2019 $2.54B Aug 6, 2020
FY2019 Jun 30, 2018 $2.68B Aug 8, 2019
FY2018 Jun 30, 2017 $3.09B Aug 9, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.33B Feb 19, 2026
FY2025 Dec 31, 2024 $260.92M Feb 19, 2026
FY2024 Dec 31, 2023 $460.42M Feb 13, 2025
FY2023 Dec 31, 2022 $781.05M Feb 15, 2024
FY2022 Dec 31, 2021 $155.82M Feb 16, 2023
FY2021 Jun 30, 2021 $148.19M Aug 12, 2021
FY2021 Jun 30, 2020 $464.17M Aug 12, 2021
FY2020 Jun 30, 2019 $373.70M Aug 6, 2020
FY2019 Jun 30, 2018 $540.75M Aug 8, 2019
FY2018 Jun 30, 2017 $773.80M Aug 9, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.16B Feb 19, 2026
FY2025 Dec 31, 2024 $3.12B Feb 19, 2026
FY2024 Dec 31, 2023 $2.89B Feb 13, 2025
FY2023 Dec 31, 2022 $2.74B Feb 15, 2024
FY2022 Dec 31, 2021 $2.59B Feb 16, 2023
FY2021 Jun 30, 2021 $2.49B Aug 12, 2021
FY2021 Jun 30, 2020 $2.27B Aug 12, 2021
FY2020 Jun 30, 2019 $2.14B Aug 6, 2020
FY2019 Jun 30, 2018 $2.10B Aug 8, 2019
FY2018 Jun 30, 2017 $2.28B Aug 9, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.23B Feb 19, 2026
FY2025 Dec 31, 2024 $889.99M Feb 19, 2026
FY2024 Dec 31, 2023 $666.52M Feb 13, 2025
FY2023 Dec 31, 2022 $527.31M Feb 15, 2024
FY2022 Dec 31, 2021 $381.93M Feb 16, 2023
FY2021 Jun 30, 2021 $286.25M Aug 12, 2021
FY2021 Jun 30, 2020 $61.13M Aug 12, 2021
FY2020 Jun 30, 2019 ($65.75M) Aug 6, 2020
FY2019 Jun 30, 2018 ($89.90M) Aug 8, 2019
FY2018 Jun 30, 2017 $88.05M Aug 9, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $233.72M Feb 19, 2026
FY2025 Dec 31, 2024 $195.50M Feb 19, 2026
FY2024 Dec 31, 2023 $104.17M Feb 13, 2025
FY2023 Dec 31, 2022 $118.59M Feb 15, 2024
FY2022 Dec 31, 2021 $143.55M Feb 16, 2023
FY2021 Jun 30, 2021 $225.92M Aug 12, 2021
FY2021 Jun 30, 2020 $319.13M Aug 12, 2021
FY2020 Jun 30, 2019 $119.48M Aug 6, 2020
FY2019 Jun 30, 2018 $88.75M Aug 8, 2019
FY2018 Jun 30, 2017 $85.85M Aug 9, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 19, 2026
FY2025 Dec 31, 2024 5 Feb 19, 2026
FY2025 Dec 31, 2023 3 Feb 19, 2026
FY2024 Dec 31, 2022 3 Feb 13, 2025
FY2023 Dec 31, 2021 2 Feb 15, 2024
FY2023 Jun 30, 2021 4 Feb 15, 2024
FY2020 Jun 30, 2020 0 Aug 6, 2020
FY2020 Mar 31, 2020 0 Aug 6, 2020
FY2020 Dec 31, 2019 0 Aug 6, 2020
FY2020 Sep 30, 2019 1 Aug 6, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 19, 2026
FY2025 Dec 31, 2024 5 Feb 19, 2026
FY2025 Dec 31, 2023 3 Feb 19, 2026
FY2024 Dec 31, 2022 3 Feb 13, 2025
FY2023 Dec 31, 2021 2 Feb 15, 2024
FY2023 Jun 30, 2021 4 Feb 15, 2024
FY2020 Jun 30, 2020 0 Aug 6, 2020
FY2020 Mar 31, 2020 0 Aug 6, 2020
FY2020 Dec 31, 2019 0 Aug 6, 2020
FY2020 Sep 30, 2019 1 Aug 6, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 84.50M Feb 19, 2026
FY2025 Oct 20, 2025 84.50M Feb 19, 2026
FY2025 Dec 31, 2024 65.69M Feb 19, 2026
FY2024 Dec 31, 2023 65.63M Feb 13, 2025
FY2023 Dec 31, 2022 65.59M Feb 15, 2024
FY2022 Dec 31, 2021 65.56M Feb 16, 2023
FY2021 Jun 30, 2021 65.55M Aug 12, 2021
FY2021 Jun 30, 2020 65.53M Aug 12, 2021
FY2020 Jun 30, 2019 65.44M Aug 6, 2020
FY2019 Jun 30, 2018 65.36M Aug 8, 2019

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $118.53M Feb 19, 2026
FY2025 Dec 31, 2024 $105.24M Feb 19, 2026
FY2025 Dec 31, 2023 $98.57M Feb 19, 2026
FY2024 Dec 31, 2022 $91.93M Feb 13, 2025
FY2023 Dec 31, 2021 $39.37M Feb 15, 2024
FY2023 Jun 30, 2021 $76.10M Feb 15, 2024
FY2022 Jun 30, 2020 $71.47M Feb 16, 2023
FY2021 Jun 30, 2019 $67.48M Aug 12, 2021
FY2020 Jun 30, 2018 $64.12M Aug 6, 2020
FY2019 Jun 30, 2017 $61.40M Aug 8, 2019